コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 implicated in regulating embryonic stem and hematopoietic progenitor cells.
2 ll cycle arrest in HSCs and profound loss of hematopoietic progenitor cells.
3 redundant and kinase-dependent functions in hematopoietic progenitor cells.
4 he levels of ESL-1 were strongly elevated in hematopoietic progenitor cells.
5 ells of the myeloid lineage, such as CD34(+) hematopoietic progenitor cells.
6 cells, eliminating the numbers of malignant hematopoietic progenitor cells.
7 and contribute to increased proliferation of hematopoietic progenitor cells.
8 e HSC/MPP pools and promote clonogenicity of hematopoietic progenitor cells.
9 ell lineage specification of mouse and human hematopoietic progenitor cells.
10 ctivation strongly enhances proliferation of hematopoietic progenitor cells.
11 as with enforced Erg expression in engrafted hematopoietic progenitor cells.
12 m that in which it occurs in primary CD34(+) hematopoietic progenitor cells.
13 ating immune cells and PTH actions on marrow hematopoietic progenitor cells.
14 differentiation and self-renewal of CD34(+) hematopoietic progenitor cells.
15 hanism in the PTH-induced increase in marrow hematopoietic progenitor cells.
16 elial progenitor cells and CD34(+)/VEGFR1(+) hematopoietic progenitor cells.
17 regulates these processes in lymphocytes and hematopoietic progenitor cells.
18 of B-lymphoid cells from fetal liver-derived hematopoietic progenitor cells.
19 erted minimal toxicity toward normal CD34(+) hematopoietic progenitor cells.
20 est the repopulation potentials of candidate hematopoietic progenitor cells.
21 mote proliferative responses in normal human hematopoietic progenitor cells.
22 fficient to increase NK cell production from hematopoietic progenitor cells.
23 Z1) or placebo delivered in autologous CD34+ hematopoietic progenitor cells.
24 ochondria compared with nonmalignant CD34(+) hematopoietic progenitor cells.
25 obin locus in human cells, including primary hematopoietic progenitor cells.
26 activated in AML cells compared with normal hematopoietic progenitor cells.
27 IR), suggesting that this steroid may act on hematopoietic progenitor cells.
28 onstrated significant loss of intestinal and hematopoietic progenitor cells.
29 al skeletal defects and increased numbers of hematopoietic progenitor cells.
30 cycling status of immature, but not mature, hematopoietic progenitor cells.
31 t increased the number of colonies formed by hematopoietic progenitor cells.
32 on, FGF2 compromises stromal cell support of hematopoietic progenitor cells.
33 function and apoptosis of AML but not normal hematopoietic progenitor cells.
34 h functions as a growth factor for primitive hematopoietic progenitor cells.
35 ell as a twofold expansion of CD34(+)CD45(+) hematopoietic progenitor cells.
36 corrects the phenotype of in vitro cultured hematopoietic progenitor cells.
37 nhancers marked with H3K4 monomethylation in hematopoietic progenitor cells.
38 ays associating with increased aneuploidy in hematopoietic progenitor cells.
39 kemia (AML) cells while not affecting normal hematopoietic progenitor cells.
40 n functions to promote a latent state within hematopoietic progenitor cells.
41 en human CML were cultured with normal human hematopoietic progenitor cells.
42 ), Ly6C(high) myeloid cells from bone marrow hematopoietic progenitor cells.
43 n led to gain of replating capacity of mouse hematopoietic progenitor cells.
44 the differentiation process of iPSCs toward hematopoietic progenitor cells.
45 est that these tumors may arise instead from hematopoietic progenitor cells.
46 iminated the total number of JAKV617F(+) MPN hematopoietic progenitor cells.
47 g is critical for the self-renewal of normal hematopoietic progenitor cells.
48 B-cell neoplasm by inducing tumorigenesis in hematopoietic progenitor cells.
49 d STAT5 on LEF-1 expression and functions in hematopoietic progenitor cells.
50 n, as it affects the differentiation of most hematopoietic progenitor cells.
51 ith significantly increased numbers of HSCs, hematopoietic progenitor cell-1 (HPC-1), HPC-2, and Lin(
52 o yield CD8 alphabeta TCR-bearing cells from hematopoietic progenitor cells, a comprehensive and func
53 both recipient and donor Tregs can influence hematopoietic progenitor cell activity after transplanta
54 ly in the erythroid lineage in primary human hematopoietic progenitor cells after expression of shRNA
56 -deficient mice engrafted with human CD34(+) hematopoietic progenitor cells and autologous T cells.
57 ed for LC differentiation from human CD34(+) hematopoietic progenitor cells and blood monocytes in vi
58 potent antigen-presenting cells derived from hematopoietic progenitor cells and circulating monocytes
60 e development of human NK cells from CD34(+) hematopoietic progenitor cells and IFN-gamma production
61 iferation and appropriate differentiation of hematopoietic progenitor cells and in animal hematopoies
62 associated with higher proliferation rate of hematopoietic progenitor cells and increased cells in ac
63 tein that confers self-renewal capability to hematopoietic progenitor cells and induces acute myeloge
64 r results show that STAT3 deficiency renders hematopoietic progenitor cells and myeloid precursors re
65 ga-dose" of T cell-depleted peripheral blood hematopoietic progenitor cells and no posttransplant pha
66 kidney transplants and an injection of CD34+ hematopoietic progenitor cells and T cells from HLA-matc
67 adiation, followed by the transplantation of hematopoietic progenitor cells and T cells from syngenei
68 the mammalian stress response gene SIRT1 in hematopoietic progenitor cells and that this involves ST
69 ed-forward loop between inflammation-adapted hematopoietic progenitor cells and the inflammatory diso
70 the effects of Hedgehog signaling within the hematopoietic progenitor cells and the magnitude of the
71 patient can be induced to differentiate into hematopoietic progenitor cells and then further to eryth
72 ired for latency and reactivation in CD34(+) hematopoietic progenitor cells and virion maturation in
73 ic stem cells (HSCs), an increased number of hematopoietic progenitor cells, and an increased proport
74 Herein we show the expression of polySia on hematopoietic progenitor cells, and demonstrate a role f
75 thma, decreased B-lymphocyte development and hematopoietic progenitor cells, and lymphoid organ hypop
76 , but is absent on normal tissues, including hematopoietic progenitor cells, and may therefore be an
77 ndogenously expressed by a mast cell line or hematopoietic progenitor cells, and specifically blocks
78 n, intermediate reactivity toward monocytes, hematopoietic progenitor cells, and T-cells was observed
79 is detected in hematopoietic stem cells and hematopoietic progenitor cells, and that its expression
82 actors (MIP-1alpha and IFNgamma) to which FA hematopoietic progenitor cells are uniquely vulnerable,
84 wth factor A (Vegf-a)-dependent apoptosis of hematopoietic progenitor cells associated with overprodu
85 is not intrinsic to defects at the level of hematopoietic progenitor cells but is associated with a
86 ytomegalovirus (HCMV) enters primary CD34(+) hematopoietic progenitor cells by macropinocytosis, wher
87 ctivity, and transformation of Frat knockout hematopoietic progenitor cells by MLL fusions results in
88 opoiesis and changes in pre-mRNA splicing in hematopoietic progenitor cells by whole transcriptome an
95 Recent studies have found that peripheral hematopoietic progenitor cells contribute to type 2 cyto
96 ing endothelial cells (CECs) and circulating hematopoietic progenitor cells (CPCs) represent two cell
97 n lymphoid progenitors, pre-pro-B cells, and hematopoietic progenitor cells (day 12 spleen colony-for
101 Applying treeHFM to time lapse images of hematopoietic progenitor cell differentiation, we demons
102 mice treated with G-CSF for mobilization of hematopoietic progenitor cells display reduced levels of
103 fies frequencies of growth-factor responsive hematopoietic progenitor cells during steady state and a
104 n attenuated strain of CMV are maintained in hematopoietic progenitor cells during their differentiat
106 combined with Peg IFN-alpha 2a can target PV hematopoietic progenitor cells, eliminating the numbers
107 reviously shown that HCMV infection of human hematopoietic progenitor cells engrafted in immune defic
109 factor in articular joints, is implicated in hematopoietic progenitor cell expansion and megakaryopoi
111 ) in acute myeloid leukemia, is required for hematopoietic progenitor cell fate decisions and for ear
113 tropenias and for mobilization of peripheral hematopoietic progenitor cells for stem cell transplanta
115 ultured from peripheral blood or bone marrow hematopoietic progenitor cells from four patients were u
116 ce-activated cell sorting (FACS) of c-kit(+) hematopoietic progenitor cells from mixed bone marrow po
117 BM) chimeras were generated by transplanting hematopoietic progenitor cells from stress-susceptible m
118 creased rDNA promoter methylation in CD34(+) hematopoietic progenitor cells from the majority of MDS
120 ranscription factor GATA-2 is vital for both hematopoietic progenitor cell function and urogenital pa
121 Expression-based studies of multipotential hematopoietic progenitor cells has shown that these cell
122 addition to resting CD4(+) T cells, CD34(+) hematopoietic progenitor cells have been proposed as ano
124 vestigate the downstream targets of HOXB4 in hematopoietic progenitor cells, HOXB4 was constitutively
126 ow that leukemic cell growth disrupts normal hematopoietic progenitor cell (HPC) bone marrow niches a
128 ly identified T cell-dependent regulation of hematopoietic progenitor cell (HPC) numbers and cycling.
129 -derived cells to the circulating definitive hematopoietic progenitor cell (HPC) pool that seeds the
130 ulation of hematopoietic stem cell (HSC) and hematopoietic progenitor cell (HPC) proliferation, survi
132 mice have greatly reduced numbers of cycling hematopoietic progenitor cells (HPC) in the BM and great
133 report that inhibition of Notch signaling in hematopoietic progenitor cells (HPC), myeloid-derived su
136 a major factor mediating interaction between hematopoietic progenitor cells (HPCs) and bone marrow st
138 ased bone marrow (BM) function and shifts in hematopoietic progenitor cells (HPCs) and lineage-commit
139 xpression of RUNX1a facilitates emergence of hematopoietic progenitor cells (HPCs) and positively reg
140 e, CCR2 was expressed on subsets of HSCs and hematopoietic progenitor cells (HPCs) and that freshly i
141 sis, we examined whether HIV-1C could infect hematopoietic progenitor cells (HPCs) and whether this p
145 oiesis characterized by increased numbers of hematopoietic progenitor cells (HPCs) at the expense of
146 but it has recently been shown that CD34(+) hematopoietic progenitor cells (HPCs) can also become la
147 hierarchy among intermediate populations of hematopoietic progenitor cells (HPCs) derived from human
149 Mouse BM hematopoietic stem cells (HSCs) and hematopoietic progenitor cells (HPCs) express CD1d.
150 , and narciclasine induced more lethality in hematopoietic progenitor cells (HPCs) expressing germlin
151 fety and effectiveness of mobilizing CD34(+) hematopoietic progenitor cells (HPCs) in adults with bet
153 nction in promoting viral latency in CD34(+) hematopoietic progenitor cells (HPCs) infected in vitro,
155 ) in promoting a latent infection in CD34(+) hematopoietic progenitor cells (HPCs) infected in vitro.
156 nocytes and mouse peritoneal macrophages and hematopoietic progenitor cells (HPCs) into myeloid DCs.
157 d CD34(+)CXCR4(+) cells as well as assayable hematopoietic progenitor cells (HPCs) irrespective of th
158 ation of hematopoietic stem cells (HSCs) and hematopoietic progenitor cells (HPCs) is crucial for cor
159 entiation of embryonic stem cells (ESC) into hematopoietic progenitor cells (HPCs) is crucial for the
161 rus (HCMV) can establish latent infection in hematopoietic progenitor cells (HPCs) or CD14 (+) monocy
162 strate that activation of Notch signaling in hematopoietic progenitor cells (HPCs) promoted different
163 However, a specific role for ADAR1 in adult hematopoietic progenitor cells (HPCs) remains elusive.
164 in mediates the enhanced survival of primary hematopoietic progenitor cells (HPCs) resulting from ITD
165 a homeobox transcription factor, to generate hematopoietic progenitor cells (HPCs) that successfully
166 resulted in a reduction in the proportion of hematopoietic progenitor cells (HPCs) that were JAK2V617
167 nduce myelosuppression of uninfected CD34(+) hematopoietic progenitor cells (HPCs) through an increas
168 To determine susceptibility of human CD34+ hematopoietic progenitor cells (HPCs) to infection with
169 Here we show that murine HSCs and committed hematopoietic progenitor cells (HPCs) undergo a gradual,
170 (HSCs), impaired radioprotective function of hematopoietic progenitor cells (HPCs), and myeloid and e
171 determine the effect of fibrosis on healthy hematopoietic progenitor cells (HPCs), bioartificial mat
172 t5 deletion resulted in a concurrent loss of hematopoietic progenitor cells (HPCs), leading to fatal
173 le entry of hematopoietic stem cells (HSCs)/ hematopoietic progenitor cells (HPCs), leading to their
175 d lung homing of bone marrow-derived CD34(+) hematopoietic progenitor cells (HPCs), which include eos
176 c stem cells (HSCs) generate highly dividing hematopoietic progenitor cells (HPCs), which produce all
191 transcriptomic profiling of normal human HSC/hematopoietic progenitor cells [HPCs], revealing that se
192 production of large numbers of primary human hematopoietic progenitor cells (HPs) capable of differen
193 ion model to investigate the role of Dot1 in hematopoietic progenitor cell immortalization by MLL fus
194 creased the proportion of JAK2V617F-positive hematopoietic progenitor cells in 6 PV patients studied.
195 eption of erythroid colonies, by maintaining hematopoietic progenitor cells in a state of proliferati
196 ontrol and fine-tune trafficking of HSCs and hematopoietic progenitor cells in embryogenesis and duri
198 n; and a 2-fold increase in the frequency of hematopoietic progenitor cells in peripheral blood.
199 e proportion of phenotypic HSCs and immature hematopoietic progenitor cells in phase G0 of the cell c
200 tly used to stimulate bone marrow release of hematopoietic progenitor cells in preparation for stem c
201 s involved in synergistic growth of immature hematopoietic progenitor cells in response to SCF plus G
202 ase in circulating levels of mesenchymal and hematopoietic progenitor cells in ROSI-treated animals.
204 hich a low ROS level is required to maintain hematopoietic progenitor cells in the tissue and to redu
206 d erythroid differentiation of primary human hematopoietic progenitor cells in vitro in the absence o
207 tivity promotes the generation of MDSCs from hematopoietic progenitor cells in vitro, demonstrating a
209 es expansion of hematopoietic stem cells and hematopoietic progenitor cells in vivo and ex vivo when
210 ed that HCMV enters into the primary CD34(+) hematopoietic progenitor cells in which it establishes l
211 y, whereas overexpression of Brn3a in murine hematopoietic progenitor cells induces terminal myeloid
213 presence of mainly alphabeta integrin in all hematopoietic progenitor cells interacting with splenic
214 ystem components by transplantation of human hematopoietic progenitor cells into NOD-scid IL2Rgamma(n
215 Spi-B is crucial for the differentiation of hematopoietic progenitor cells into pDCs by controlling
216 for E-selectin binding and for migration of hematopoietic progenitor cells into the bone marrow.
217 CCR9 controls the immigration of multipotent hematopoietic progenitor cells into the thymus to sustai
218 skewing promote oncogenic transformation of hematopoietic progenitor cells into therapy-resistant le
223 by which that occurs, using an immortalized hematopoietic progenitor cell line, EML-C1, as a model s
225 igratory responses of cocultured stromal and hematopoietic progenitor cell lines, helping explain how
226 including induced intracellular signaling in hematopoietic progenitor cells, lymphocytes, other innat
227 factor (VEGF), VEGF receptor, and CD34/CD31 (hematopoietic progenitor cell marker/endothelial cell ma
230 ts receptor, CXCR4, are essential for normal hematopoietic progenitor cell movement and adherence wit
231 Thus, Id1 is required for regulating the hematopoietic progenitor cell niche but is dispensable f
232 quantification of circulating EPC number and hematopoietic progenitor cell number and for analysis of
233 on of hematopoietic stem cells and decreases hematopoietic progenitor cell numbers both in vivo and i
235 cells, we transduced lineage-depleted murine hematopoietic progenitor cells, observing GFP expression
237 lacked the N-terminal DNA-binding domain in hematopoietic progenitor cells of reconstituted mice.
241 ability in hematopoietic stem cell (HSC) and hematopoietic progenitor cell populations from young and
242 Somatic mutations were tracked to CD34(+) hematopoietic progenitor cell populations, being further
243 5azaD/TSA treatment, JAK2V617F-negative PMF hematopoietic progenitor cells preferentially homed to t
244 lation and the expression of PML-RARalpha in hematopoietic progenitor cells prevented differentiation
245 ients with systemic histiocytoses resides in hematopoietic progenitor cells prior to committed monocy
246 ation of ERK in these cells led to rescue of hematopoietic progenitor cell proliferation in vitro and
248 ug sensitivity, and abrogated MPP1-dependent hematopoietic progenitor cell replating in methylcellulo
249 e that myeloid lineage identity of malignant hematopoietic progenitor cells requires the residual exp
250 asia, fibrosis, and impaired colonization by hematopoietic progenitor cells, resulting in anemia and
251 metry analysis of MDSCs generated from mouse hematopoietic progenitor cells revealed that the CD11b(+
253 of T-lineage specification in human CD34(+) hematopoietic progenitor cells, similar to ICN1 overexpr
254 high-dose chemotherapy (HDC) with autologous hematopoietic progenitor cell support (AHPCS) with a mod
255 ptor tyrosine kinase with important roles in hematopoietic progenitor cell survival and proliferation
257 ells are a novel source of cells, especially hematopoietic progenitor cells that can be used to treat
258 shown to more efficiently differentiate into hematopoietic progenitor cells that engrafted in allogen
259 etic development, and found defects in early hematopoietic progenitor cells that were propagated thro
261 Although both ligands activated Notch in hematopoietic progenitor cells, they had an opposite eff
262 em cells (HSCs) can result in high yields of hematopoietic progenitor cells, this generally occurs at
263 tion here of HCMV entry into primary CD34(+) hematopoietic progenitor cells through macropinocytosis
265 elogenous leukemia (CML) caused normal mouse hematopoietic progenitor cells to divide more readily, a
268 the mechanisms that govern the adaptation of hematopoietic progenitor cells to inflammation and its s
270 ted the capacity of human CB-derived CD34(+) hematopoietic progenitor cells to regenerate injured alv
271 used gamma-irradiated primary human CD34(+) hematopoietic progenitor cells to show that 5-AED protec
272 ged mice correlated with reduced adhesion of hematopoietic progenitor cells to stroma and with elevat
274 t al. demonstrate that TLR signals also bias hematopoietic progenitor cells toward myelopoiesis direc
275 er therapy, an autologous transplantation of hematopoietic progenitor cells transduced ex vivo with a
278 of high-risk adenovirus infections following hematopoietic progenitor cell transplantation prior to,
279 s of thrombotic microangiopathy secondary to hematopoietic progenitor cell transplantation, infection
281 romote AML, we coexpressed both mutations in hematopoietic progenitor cells used to reconstitute leth
283 rvival-enhancing effects on irradiated human hematopoietic progenitor cells via induction, stabilizat
285 ably, sustained expression of EBF in Pax5-/- hematopoietic progenitor cells was sufficient to block t
286 d increase in marrow Lin(-)Sca-1(+)c-Kit(+) (hematopoietic progenitor) cells was blunted in mutant mi
287 t-like or a replicative infection in CD34(+) hematopoietic progenitor cells, we defined classes of lo
288 ssion and ex vivo differentiation of CD34(+) hematopoietic progenitor cells, we demonstrate that C/EB
290 rect target genes of HOXB4 in primary murine hematopoietic progenitor cells, we induced HOXB4 functio
291 nant-negative ETS1 p27 isoform in cord blood hematopoietic progenitor cells, we show that the transcr
293 of survival and replating capacity of human hematopoietic progenitor cells were observed with CXCL12
294 (FL) contained normal numbers of functional hematopoietic progenitor cells, were radioprotective, an
295 , we examined the entry of HCMV into CD34(+) hematopoietic progenitor cells where the virus establish
296 o significant effect up to 1000 nM on normal hematopoietic progenitor cells, whereas in AML patient s
297 l pathway activated by BCR-ABL expression in hematopoietic progenitor cells, which promotes oncogenic
298 ly suppresses the growth and expansion of PV hematopoietic progenitor cells while having little effec
299 y glycosyltransferases, and decorates marrow hematopoietic progenitor cells with alpha2,6-linked sial
300 f a human cell AML, generated in CD34+ human hematopoietic progenitor cells xenografted into immunoco